We then selected ABCB1 for further study, because ABCB1 is a well-known tumor-promoting gene reported by many studies[16–17], and the difference of ABCB1 in sequencing results after SNHG16 knockdown was statistically significant (Fig. 4A). This evidence concerns the gene ABCB1 and neoplasm.